Evidence map›Paper›PMID 33875564›Full record

ArticleJournal of medical genetics2022

Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository.

Chloe Mighton, Amanda C Smith, Justin Mayers, Robert Tomaszewski, Sherryl Taylor, Stacey Hume, Ron Agatep, Elizabeth Spriggs, Harriet E Feilotter, Laura Semenuk and 24 more

Abstract read
In one paragraph

Article in Journal of medical genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. A Novel Frameshift Mutation inBiomedicines · 2026
    Article
  3. MaveMD: A functional data resource for genomic medicine.medRxiv : the preprint server for health sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. State of open science in cancer research.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Chloe MightonInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Amanda C SmithCHEO Research Institute, Ottawa, Ontario, Canada.
Justin MayersPathology and Laboratory Medicine, Mount Sinai Hospital, Sinai Health, Toronto, Ontario, Canada.
Robert TomaszewskiAlberta Precision Laboratories, Edmonton, Alberta, Canada.
Sherryl TaylorAlberta Precision Laboratories, Edmonton, Alberta, Canada.
Stacey HumeAlberta Precision Laboratories, Edmonton, Alberta, Canada.
Ron AgatepShared Health, Winnipeg, Manitoba, Canada.
Elizabeth SpriggsShared Health, Winnipeg, Manitoba, Canada.
Harriet E FeilotterKingston Health Sciences Centre, Kingston, Ontario, Canada.
Laura SemenukKingston Health Sciences Centre, Kingston, Ontario, Canada.
Henry WongKingston Health Sciences Centre, Kingston, Ontario, Canada.
Lorena Lazo de la VegaLaboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, Cambridge, Massachusetts, USA.
Christian R MarshallGenome Diagnostics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Michelle M AxfordGenome Diagnostics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Talia SilverGenome Diagnostics, The Hospital for Sick Children, Toronto, Ontario, Canada.
George S CharamesPathology and Laboratory Medicine, Mount Sinai Hospital, Sinai Health, Toronto, Ontario, Canada.
Vanessa Di GioacchinoPathology and Laboratory Medicine, Mount Sinai Hospital, Sinai Health, Toronto, Ontario, Canada.
Nicholas WatkinsPathology and Laboratory Medicine, Mount Sinai Hospital, Sinai Health, Toronto, Ontario, Canada.
William D FoulkesDepartments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada.ORCID 0000-0001-7427-4651
Marcos ClavierLady David Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Nancy HamelResearch Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
George ChongLady David Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Ryan E LamontDepartment of Medical Genetics, University of Calgary, Calgary, Alberta, Canada.
Jillian ParboosinghDepartment of Medical Genetics, University of Calgary, Calgary, Alberta, Canada.
Aly KarsanDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Ian BosdetDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Sean S YoungDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Tracy TuckerDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Mohammad Reza AkbariWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
Marsha D SpeevakTrillium Health Partners, Mississauga, Ontario, Canada.
Andrea K VaagsTrillium Health Partners, Mississauga, Ontario, Canada.
Matthew S LeboLaboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, Cambridge, Massachusetts, USA.
Jordan Lerner-EllisPathology and Laboratory Medicine, Mount Sinai Hospital, Sinai Health, Toronto, Ontario, Canada jordan.lerner-ellis@sinaihealth.ca.ORCID 0000-0003-3685-5679
Canadian Open Genetics Repository Working Group

Funding

Integrated pathogenicity assessment of clinically actionable genetic variantsR01HG010372 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI CASSA, CHRISTOPHER · 2018 to 2022
$3.5M
NHGRI NIH HHS R01 HG010372
6 · The paper itself

Abstract

backgroundThis study aimed to identify and resolve discordant variant interpretations across clinical molecular genetic laboratories through the Canadian Open Genetics Repository (COGR), an online collaborative effort for variant sharing and interpretation.

methodsLaboratories uploaded variant data to the Franklin Genoox platform. Reports were issued to each laboratory, summarising variants where conflicting classifications with another laboratory were noted. Laboratories could then reassess variants to resolve discordances. Discordance was calculated using a five-tier model (pathogenic (P), likely pathogenic (LP), variant of uncertain significance (VUS), likely benign (LB), benign (B)), a three-tier model (LP/P are positive, VUS are inconclusive, LB/B are negative) and a two-tier model (LP/P are clinically actionable, VUS/LB/B are not). We compared the COGR classifications to automated classifications generated by Franklin.

resultsTwelve laboratories submitted classifications for 44 510 unique variants. 2419 variants (5.4%) were classified by two or more laboratories. From baseline to after reassessment, the number of discordant variants decreased from 833 (34.4% of variants reported by two or more laboratories) to 723 (29.9%) based on the five-tier model, 403 (16.7%) to 279 (11.5%) based on the three-tier model and 77 (3.2%) to 37 (1.5%) based on the two-tier model. Compared with the COGR classification, the automated Franklin classifications had 94.5% sensitivity and 96.6% specificity for identifying actionable (P or LP) variants.

conclusionsThe COGR provides a standardised mechanism for laboratories to identify discordant variant interpretations and reduce discordance in genetic test result delivery. Such quality assurance programmes are important as genetic testing is implemented more widely in clinical care.

Indexed as

Genetic VariationLaboratoriesCanadaGenetic Predisposition to DiseaseGenetic TestingHumansInformation Disseminationgeneticsgenetic testinghuman genetics

Identifiers

PMID33875564
PMCPMC8523590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.